Pyrazolopyrrolidine compounds
US8969341B2 · kind B2 · utility
7Cited by
4References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 28, 2012 |
| Grant date | Mar 3, 2015 |
| Priority date | — |
| Expiry date | Nov 28, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds of formula (I) as described herein, pharmaceutical preparations comprising such compounds, uses and methods of use for such compounds in the treatment of a disorder or a disease mediated by the activity of MDM2 and/or MDM4, and combinations comprising such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.